Reimbursement Dispute Between Novitas And iRhythm Hits An Impasse

Local Medicare carrier Novitas raised its reimbursement rates for continuous cardiac monitoring, but iRhythm has concluded the rates are still too low and is preparing to discontinue serving this Medicare segment.

Two business teams and money between them. Tender and financial competition concept. Fight for financing. Money sharing. Distribution of funds. - Image ID: 2C4Y628
• Source: Alamy

The ongoing dispute between payers and manufacturers over Medicare reimbursement rates for continuous cardiac monitoring is unlikely not be resolved soon.

Since the end of January, a consortium of monitoring device companies, led by iRhythm Technologies, has been working with Texas-based Medicare Administrative Contractor Novitas to agree on Medicare reimbursement...

More from Policy & Regulation

More from Medtech Insight